DECODE - Haemodynamic Effects Of Semaglutide and Tirzepatide - a Series of Pilot Studies

A phase 4 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 112 participants.

Also called NCT07483801

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose basic science
Phase
Phase 4
Enrolled
  • 112 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT07483801
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United Kingdom (from the registry)
Registry status
  • Not yet recruiting (from the registry)

Technical summary

Registry record NCT07483801. Randomized; double masking; primary purpose basic science. Start 2026-03 (anticipated); primary completion 2027-04 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
DECODE - Haemodynamic Effects Of Semaglutide and Tirzepatide - a Series of Pilot Studies
Acronym
DECODE
Condition
Cardiovascular Diseases
Intervention (Drug)
semaglutide
Intervention (Drug)
Tirzepatide
Lead sponsor
Cambridge University Hospitals NHS Foundation Trust (class: other)

Record details

Record id
cardio:ct-nct07483801
Content hash
ca6f6720019346bcaefa3eb8f5458324b6c34d5cd68962048b6b3244fa6e0c56